title: Decolonisation of MRSA, S. aureus and E. coli by cold-atmospheric plasma using a porcine skin model in vitro.
abstract: In the last twenty years new antibacterial agents approved by the U.S. FDA decreased whereas in parallel the resistance situation of multi-resistant bacteria increased. Thus, community and nosocomial acquired infections of resistant bacteria led to a decrease in the efficacy of standard therapy, prolonging treatment time and increasing healthcare costs. Therefore, the aim of this work was to demonstrate the applicability of cold atmospheric plasma for decolonisation of Gram-positive (Methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus) and Gram-negative bacteria (E. coli) using an ex vivo pig skin model. Freshly excised skin samples were taken from six month old female pigs (breed: Pietrain). After application of pure bacteria on the surface of the explants these were treated with cold atmospheric plasma for up to 15 min. Two different plasma devices were evaluated. A decolonisation efficacy of 3 log(10) steps was achieved already after 6 min of plasma treatment. Longer plasma treatment times achieved a killing rate of 5 log(10) steps independently from the applied bacteria strains. Histological evaluations of untreated and treated skin areas upon cold atmospheric plasma treatment within 24 h showed no morphological changes as well as no significant degree of necrosis or apoptosis determined by the TUNEL-assay indicating that the porcine skin is still vital. This study demonstrates for the first time that cold atmospheric plasma is able to very efficiently kill bacteria applied to an intact skin surface using an ex vivo porcine skin model. The results emphasize the potential of cold atmospheric plasma as a new possible treatment option for decolonisation of human skin from bacteria in patients in the future without harming the surrounding tissue.
authors.affiliation: Department of Dermatology, Regensburg University Hospital, Regensburg, Bavaria, Germany.
authors.forename: Tim
authors.initials: T
authors.lastname: Maisch
authors.forename: Tetsuji
authors.initials: T
authors.lastname: Shimizu
authors.forename: Yang-Fang
authors.initials: YF
authors.lastname: Li
authors.forename: Julia
authors.initials: J
authors.lastname: Heinlin
authors.forename: Sigrid
authors.initials: S
authors.lastname: Karrer
authors.forename: Gregor
authors.initials: G
authors.lastname: Morfill
authors.forename: Julia L
authors.initials: JL
authors.lastname: Zimmermann
mesh_terms: D000818:Animals; D004203:Disinfection / Q000379:methods*; D004926:Escherichia coli / Q000187:drug effects*; D005260:Female; D006652:Histological Techniques; D020287:In Situ Nick-End Labeling; D066298:In Vitro Techniques; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D058626:Plasma Gases / Q000494:pharmacology*; D012867:Skin / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects*; D034421:Sus scrofa; D013997:Time Factors
chemical_list: D058626:Plasma Gases